U.S. Wealth WatcherCelebrating Political Fortunes
S 4189 · 119th CongressIntroduced

Caps insulin costs at $35 per month

Health & Pharma
The vote
—
Worked the bill
$426M
24 groups · their total 2025 lobbying
In the distance
—
Summary

What the bill does

This bill would cap the amount patients with private insurance pay for insulin at $35 per month. It also requires insurers to cover at least one of each type and form of insulin without a deductible. The bill aims to make insulin more affordable and increase competition among drugmakers.

Why it matters

The stakes

Millions of Americans with diabetes rely on insulin to stay alive. High prices can force people to ration their medication, which is dangerous. This bill could lower out-of-pocket costs for many insured patients.

Major public companies this covers
  • Eli LillyLLY
  • Novo NordiskNVO
  • SanofiSNY
The debate

What each side says

Supporters
  • Caps insulin copays at $35 per month, making it more affordable for patients with private insurance.bill
  • Eliminates deductibles for insulin, so patients get the benefit from the start of the year.bill
  • Requires insurers to cover at least one of each type and form of insulin, ensuring patients have access to the kind they need.bill
  • Includes measures to increase competition among insulin makers and biosimilars, which could lower prices over time.bill
Critics
  • The bill does not address the underlying list prices set by drug companies, only what patients pay at the pharmacy.report
  • It may lead to higher premiums for everyone if insurers pass on the cost of capped copays.report

Each point links to its source. The views are attributed to those sources, not stated as ours.

Follow the money

From this bill outward

The bill

where every tie is measured from
S 4189Caps insulin costs at $35 per monthHealth & Pharma

Who paid lobbyists to work it

Direct tie24 groups · their total 2025 lobbying
GroupIssues2025 lobbying
(all issues)
Has PAC?
ELI LILLY AND COMPANY›Named in billHealthForeignBanking$11M✓ELACPAC
NOVO NORDISK, INC.›Named in billHealthOtherBanking$7.2M✓NNIPNNP
SANOFI US SERVICES INC.›Named in billHealthBankingTech$6.3M✓SUSIEP
CHAMBER OF COMMERCE OF THE U.S.A.›EnergyBankingForeign$70M✗No PAC
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA›HealthTechForeign$38M✓PRAMAOAP
BUSINESS ROUNDTABLE INC›EnergyBankingHealth$34M✗No PAC
AMERICAN HOSPITAL ASSOCIATION›HealthOtherForeign$25M✓AHAP
AMERICAN MEDICAL ASSOCIATION›HealthForeignOther$23M✗No PAC

Election money, in the distance

Background · not tied to this billHealth & Pharma PACs -> the members who voted

The background money view appears when a bill has a recorded vote and matching sector PAC data.

Lobbying filings, contributions, and votes are public records shown side by side. The further down the chain, the further the money is from this bill. This page does not assert that money caused any vote.